IMPACT OF BRCA & PD-L1 IN EOC PATIENTS RECEIVING STANDARD 1ST LINE THERAPY plus /- PEMBROLIZUMAB: EXPLORATORY ANALYSES FROM THE NEOPEMBROV STUDY (GINECO)
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要